- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04820400
Reducing Pain and Anxiety During Dressing Changes After Burn Surgery Using Virtual Reality (BURN-360)
BURN 360: Reducing Pain and Anxiety During Dressing Changes After Burn Surgery Using Virtual Reality
Burn injury and its treatment is an intensely painful experience. Most severely injured patients require numerous dressing changes and skin grafting procedures (removing skin from healthy part of the body and moving it to damaged area of the body). This procedure cause extensive pain and anxiety and many patients can become dependent on pain killers during their hospital stay and throughout rehabilitation. This can delay reintegration into society and increase the chance of opioid dependence. An effective pain management plan plays a large role in patient recovery.
In addition to the physical pain experienced by these patients, burn injury is an intensely stressful and emotional life experience. This study will use a non-drug approach to reduce pain and extensive use of pain killers (opioids) during dressing changes. In particular, the study will use an immersive (allows to experience computer-generated environment as a real world) Virtual reality (VR) distraction tool during dressing change after skin graft surgery. Individuals who will decide to participate in this study will be asked to wear headgear to view immersive 360 videos specially designed by the study team. Before and after this exposure participants will be asked to complete a measurement of their anxiety level (VAS) and rate their pain.
This study will help to determine if using VR as a distraction tool during painful dressing changes will reduce pain and anxiety, and therefore opioid medications requirements, and will rely on participants experience and adapt VR videos according to participants' response.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Ross Tilley Burn Centre (RTBC) is the largest burn care centre in Canada, admitting ~300 patients/year. Most of these severely injured patients require numerous dressing changes and skin grafting procedures which cause extensive pain and anxiety in patients already facing potential losses in terms of function and independence. Poorly managed pain can reduce patient engagement and participation in effective rehabilitation, result in chronic opioid dependence, and worsen post-traumatic stress disorder.
While burn health practitioners specialize in the use of multi-modal pharmacological approach in an attempt to reduce patients' reliance on opioid, there is an increasing recognition of the importance of non-pharmacological strategies to reduce painful procedures in hospital. A number of studies have demonstrated reductions in pain, anxiety and analgesic medications with the use of Virtual Reality (VR) during procedures in hospital. VR can be applied in a variety of ways, with considerable variations in terms of cost, efficacy, and applicability. The burn injury VR literature includes predominantly small cases/series and is lacking on using VR-360 videos as a distraction technique in burn patients. Thus, VR remains under-utilized in most burn centres locally and internationally. To address this lack of knowledge, this study proposes to use VR-360 video as a distraction tool in patients during dressing changes after skin graft surgery.
This study aims to improve burn pain management by reducing opioid requirements, pain and anxiety during painful dressing changes, while also improving patient safety and satisfaction.
The study hypothesis is that immersive virtual reality use in the burn centre will reduce the cumulative dosage of analgesia used during the first two dressing changes after skin graft surgery when compared with patients not utilizing the technology.
The primary objective of this study is to evaluate the effect of VR-360 distraction video on opioid analgesic consumption during burn dressing changes.
The secondary objectives are to investigate the effect of VR-360 on pain, requirement for conscious sedation, additive effect of multiple VR exposures, anxiety, dressing change efficiency, patient reported outcome and satisfaction. Finally, patient and staff surveys will be undertaken which will allow iterative adaptation of 3600 immersive videos to the patients' preferences optimal distraction from the painful stimuli during dressing change.
The majority of patients suffering from burn injuries are committed to undergoing long, complex treatment plans that have significant physical and emotional impact. Pain is a challenge within this population and many patients require high doses of opioids. Indeed, a sizable proportion of burn patients may still require opioids as long as three months after discharge, delaying their reintegration into society and increasing the chance of opioid dependence. VR is a strategy that helps patients alter pain behavior. This study will be the first randomized trial to apply practitioner-designed VR-videos with patient input for greatest impact. It will compare opioid use, pain scores and patient satisfaction scores between this new, state of the art intervention, and current standard practice. By demonstrating VR's 'non-pharmacologic' effectiveness to alter pain perception the study team will develop a cost-effective, accessible tool that can align with practice at Sunnybrook. Furthermore, this team-based quality improvement initiative involving nurses, social workers, physio/occupational therapy and physicians aims to introduce VR as an evidence-based innovative non-pharmacological strategy to reduce opioid requirements and optimize the use of resources, workflow, and improve staff experience in burn centres across Canada and internationally
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alan D Rogers, MD
- Phone Number: 3769 416 480 6100
- Email: alandavid.rogers@sunnybrook.ca
Study Contact Backup
- Name: Fahad Alam, MD
- Phone Number: 416 480 4864
- Email: fahad.alam@sunnybrook.ca
Study Locations
-
-
-
Toronto, Canada
- Recruiting
- Sunnybrook Research Institute
-
Contact:
- Catherine Parry
- Phone Number: 416-480-4276
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥ 18
- Patients anticipated to receive only one skin autograft surgery for acute burn injury at RTBC (patients may have received an allograft skin procedure prior to the autograft)
- Patients who will require inpatient stay for at least two consecutive daily dressing changes
- Patients alert and oriented, and able to watch immersive video and respond to questions
Exclusion Criteria:
- Patients on mechanical ventilation
- Patients receiving intravenous sedation
- Patients with significant face, neck or scalp burn wounds
- Patients with confirmed resistant bacteria (MRSA, CPE, VRE)
- Patients with history of significant motion sickness (i.e. occur during exposure to physical, visual and virtual motion, cybersickness, etc.) verbally declared by patient
- Patients unable to communicate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: VR-360 group (VR-group)
Patients will watch a VR-360 distraction video during dressing change.
The patient will be asked or helped to wear the HMD write in full at the onset of a procedure and watch the VR-360 video during the dressing change procedure.
When experiencing pain, the patient may indicate the need for further analgesic medication during the procedure, the patient will be asked to push a button in their hand that will trigger a light-based signal for the nurse to provide further analgesic medication.
Should their hands both be involved in the burn injury, the patient will indicate the same verbally.
|
The VR-360 video will be custom-made for the burn patient population. Through a review of current evidence for video scenarios/patients surveys, the study team will define and implement the key components appropriate for acute procedural pain such as type, duration and severity in this patient population. Next, patients will be asked about preferred pain relief elements (e.g. individual colours, geographical locations, sounds, etc.) that would help to design a video scenario. Finally, using a Likert pain scale, patients will be asked to rate each individual descriptor that exacerbates or alleviates pain. For instance, the colour red may be associated with 'flames', 'heat' and 'burns', and thus elevated pain, the colour blue may have the opposite effect, representing 'cooling' or 'cold'. Combined, this information will be used to create a VR-360 video geared towards alleviating acute procedural pain in patients with burn injuries undergoing dressing changes after skin graft. |
No Intervention: Control Group (standard treatment)
The patients will receive standard treatment and will be instructed to use the same button to indicate their pain.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cumulative opioid analgesia consumption
Time Frame: Peri-procedural (starting 4 hours before and ending 4 hours after the dressing change)
|
Cumulative opioid dose (i.e.
fentanyl, hydromorphone, etc.) during the first 2 dressing change sessions in intravenous morphine equivalents (IME).
|
Peri-procedural (starting 4 hours before and ending 4 hours after the dressing change)
|
Change in opioid consumption between the first two dressing changes
Time Frame: Peri-procedural (starting 4 hours before and ending 4 hours after the dressing change)
|
Opioid consumption over the first 2 dressing changes will be assessed between the two groups and differences will be compared between two consequent dressing change events (Dressing Change Day 1 and Dressing Change Day 2).
We will also compare the cumulative doses for both dressing events.
|
Peri-procedural (starting 4 hours before and ending 4 hours after the dressing change)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain assessment
Time Frame: Immediately before, during and after each dressing change
|
Study participants will rate their pain using the Numeric Rating Scale for Pain (NRS) on a scale of 0-10 (0 for no pain; 10 for unbearable pain)
|
Immediately before, during and after each dressing change
|
Additive effect of VR exposure on pain
Time Frame: 2 dressing changes: Day 1 and Day 2
|
The dose difference in opioid will be calculated and compared between two consequent dressing change events.
|
2 dressing changes: Day 1 and Day 2
|
Anxiety assessment
Time Frame: immediately before dressing change, during and after each dressing change (30 minutes after procedure complete)
|
Participants will rate their anxiety using the Visual Analogue Scale for anxiety (VASa), a 0-10 scale where 0 is "Not at all anxious" and 10 is "Extremely anxious".
|
immediately before dressing change, during and after each dressing change (30 minutes after procedure complete)
|
Number of participants requiring conscious sedation
Time Frame: assessed during the dressing procedure
|
The requirement for additional intravenous sedatives: ketamine (25mg IV q 5mins with no max and/or midazolam 1mg q15min (MD clinical discretion) or fentanyl (25-50 mcg IV q5 min, maximum total dose of 250mcg)
|
assessed during the dressing procedure
|
Dressing change efficiency
Time Frame: immediately after dressing change procedure on the day of procedure
|
The dressing nurse will complete a standardized workflow questionnaire using a 0-10 Likert scale (0 as not efficient and 10 as very efficient).
|
immediately after dressing change procedure on the day of procedure
|
Patient satisfaction: survey
Time Frame: assessed after 2nd dressing change on the day of procedure
|
Will be assessed with a survey asking patients subjective thoughts on the procedure experience.
|
assessed after 2nd dressing change on the day of procedure
|
Opioid use at 3 months
Time Frame: Assessed 3 months after the procedure
|
This will be a binary outcome.
Whether the patient is on prescription opioid analgesics or not at the 3-month follow-up visit.
|
Assessed 3 months after the procedure
|
Post-Traumatic Stress Disorder Assessment
Time Frame: Assessed 1) at baseline 2) after 2nd dressing procedure, 3) at discharge, 4) at 3 month follow up visit
|
All participants will be asked to complete the PTSD checklist for DSM-5 (PCL-5), which asks 20 questions related to symptoms of PTSD, each of which is ranked on a 0-4 scale, where 0 is "Not at all" and 4 is "extremely".
|
Assessed 1) at baseline 2) after 2nd dressing procedure, 3) at discharge, 4) at 3 month follow up visit
|
Collaborators and Investigators
Investigators
- Principal Investigator: Alan D Rogers, MD, SHSC
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BURN-360
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Postoperative
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Ankara City Hospital BilkentRecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | SternotomyTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Aydin Adnan Menderes UniversityCompleted
-
Aydin Adnan Menderes UniversityCompletedAcute Postoperative Pain | Chronic Postoperative PainTurkey
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown
-
VA Office of Research and DevelopmentRecruitingTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty (Postoperative Pain)United States
-
VA Office of Research and DevelopmentCompletedTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty(Postoperative Pain)United States
Clinical Trials on Immersive VR Video
-
University Health Network, TorontoCentre for Aging and Brain Health InnovationCompleted
-
Virginia Commonwealth UniversityRecruiting
-
University Health Network, TorontoPerley RideauRecruitingVision, Low | Visual ImpairmentCanada
-
University of Southern CaliforniaFront Porch Center for Innovation and WellbeingTerminatedMild Cognitive Impairment | Mild DementiaUnited States
-
Kathleen FrielUnknown
-
Cyprus University of TechnologyUniversity of CyprusCompleted
-
University Health Network, TorontoCentre for Aging and Brain Health Innovation; Ontario AHSC AFP Innovation FundNot yet recruiting
-
Institut d'Investigacions Biomèdiques August Pi...Not yet recruitingLow Back Pain | Chronic PainSpain
-
First Affiliated Hospital of Chongqing Medical...Not yet recruiting
-
Children's Hospital Medical Center, CincinnatiCompletedPain | Pain, Postoperative | Anxiety PostoperativeUnited States